A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
The investigators are looking for a better way to prevent cervical cancer. This study is comparing two different methods to...
TB is a major cause of illness and death in women of reproductive age. Pregnant and postpartum women with latent TB are at...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
